The best metric is not weight, but a particularly toxic kind of fat.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

As more people take GLP-1 medications for weight loss, dietitians are seeing their appointments booked out for months.

News Evidence That GLP-1 Drugs Achieve Weight Loss Primarily by Reducing Fat Mass More Than Muscle. Diabetes and obesity have become pressing health issues worldwide. Glucagon-lik ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Weight loss jabs, also known as GLP-1 receptor agonists, work by reducing food cravings. Giving obese children weight-loss ...

If you're considering taking a GLP-1 medication, and you also have a digestive condition, you may be wondering about side ...